Literature DB >> 8422831

Can islet cell antibodies predict IDDM in the general population?

P J Bingley1, E Bonifacio, M Shattock, H A Gillmor, P A Sawtell, D B Dunger, R D Scott, G F Bottazzo, E A Gale.   

Abstract

OBJECTIVE: To evaluate the likely prognostic significance of ICAs in children with no family history of IDDM. RESEARCH DESIGN AND METHODS: We examined the prevalence of ICAs in 2925 English schoolchildren aged 9-13 yr and in 274 age-matched siblings of children with diabetes from the same region, and we compared the estimated risk of progression to diabetes within 10 yr in the two groups.
RESULTS: ICAs were present at levels > or = 4 JDF U in 2.8% of schoolchildren and 6.6% of siblings and at > or = 20 JDF U in 0.8% of schoolchildren and 2.2% of siblings. Although ICAs are only 2-3 times more prevalent in siblings than schoolchildren, the estimated cumulative risk that siblings will progress to diabetes by age 21 is 13 times greater (2.8 vs. 0.21%).
CONCLUSIONS: ICAs are unexpectedly prevalent in English schoolchildren, but only a small minority, with this evidence of immune activation directed against islet cells, will progress to diabetes. Although ICAs alone have limited predictive value in the general population, combining two or more predictive tests in series could achieve a level of prediction equivalent to that now obtained in first-degree relatives.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8422831     DOI: 10.2337/diacare.16.1.45

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  16 in total

Review 1.  Prediction and prevention of type I diabetes.

Authors:  R Gianani; G S Eisenbarth
Journal:  J Endocrinol Invest       Date:  1994 Jul-Aug       Impact factor: 4.256

Review 2.  Advances in childhood onset diabetes.

Authors:  J P Shield; J D Baum
Journal:  Arch Dis Child       Date:  1998-04       Impact factor: 3.791

Review 3.  Distinct clinical and laboratory characteristics of latent autoimmune diabetes in adults in relation to type 1 and type 2 diabetes mellitus.

Authors:  Elena Pipi; Marietta Marketou; Alexandra Tsirogianni
Journal:  World J Diabetes       Date:  2014-08-15

4.  Value of antibodies to GAD65 combined with islet cell cytoplasmic antibodies for predicting IDDM in a childhood population.

Authors:  H J Aanstoot; E Sigurdsson; M Jaffe; Y Shi; S Christgau; D Grobbee; G J Bruining; J L Molenaar; A Hofman; S Baekkeskov
Journal:  Diabetologia       Date:  1994-09       Impact factor: 10.122

Review 5.  Autoantibodies in insulin-dependent diabetes mellitus.

Authors:  E Bosi; E Bonifacio
Journal:  J Endocrinol Invest       Date:  1994 Jul-Aug       Impact factor: 4.256

6.  Immune response to glutamic acid decarboxylase correlates with insulitis in non-obese diabetic mice.

Authors:  A Cooke; T E Mandel
Journal:  J Endocrinol Invest       Date:  1994 Jul-Aug       Impact factor: 4.256

Review 7.  New concepts in diabetes mellitus. I: Treatment, pregnancy and aetiology.

Authors:  R Taylor; M Vanderpump
Journal:  Postgrad Med J       Date:  1994-06       Impact factor: 2.401

8.  Anti-37kDa antibodies are associated with the development of IDDM in individuals with islet cell antibodies.

Authors:  J C Ongagna; C Levy-Marchal
Journal:  Diabetologia       Date:  1995-03       Impact factor: 10.122

9.  Importance of persistent cellular and humoral immune changes before diabetes develops: prospective study of identical twins.

Authors:  R Y Tun; M Peakman; L Alviggi; M J Hussain; S S Lo; M Shattock; D A Pyke; G F Bottazzo; D Vergani; R D Leslie
Journal:  BMJ       Date:  1994-04-23

10.  The ethics of type 1 diabetes prediction and prevention research.

Authors:  Lainie Friedman Ross
Journal:  Theor Med Bioeth       Date:  2003
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.